Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: The impact of trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis on the occurrence of asymptomatic bacteriuria and urinary tract infections among renal allograft recipients: a retrospective before-after study

Fig. 2

a. Antimicrobial resistance pattern of all Escherichia coli (E. coli) isolates (n = 128) cultured within one year after transplantation according to exposure to TMP-SMX as PJP prophylaxis. amox = amoxicillin. amox-clav = amoxicillin-clavulanic acid. cipro = ciprofloxacin. nitro = nitrofurantoin. TMP-SMX = trimethoprim-sulfamethoxazole. ESBL = Extended Spectrum beta-Lactamase. R = resistant. b and c Amoxicillin and TMP-SMX resistance among E. coli according to exposure to TMP-SMX as PJP prophylaxis. E.coli. isolates are categorised in three time groups. First group consists of E. coli isolates cultured within 30 days after transplantation (“early” time-frame). The second group consists of E. coli isolates cultured within 31-180 days after transplantation (intermediate time-frame). The third group consists of E. coli isolates cultured after 181 till 365 days after transplantation (“late” time-frame)

Back to article page